| payload |
{"created_at":"2026-04-14T02:04:49.876 {"created_at":"2026-04-14T02:04:49.876253+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:34207a5010a79c84","evidence_event_ids":["evt_555f309eb405"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001766522-26-000009.txt","as_of":"2026-04-14T02:04:49.876253+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001766522-26-000009.txt","company":"Whitehawk Therapeutics, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001766522-26-000009.txt","article_chars":2030,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_4571fe68a3b3414a","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001766522-26-000009.txt","content_type":"text/plain","enriched_at":"2026-04-14T02:09:26.175847+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001766522-26-000009.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001766522-26-000009.txt","source_event_id":"evt_555f309eb405","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"328780d165d31f71","kind":"sec_filing","published_at":"20260413","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-13","2026-04-09","2026-04-10","2026-04-09"],"entities":[{"asset_class":"equity","name":"Whitehawk Therapeutics, Inc.","relevance":"high","symbol":"WHWK","type":"issuer"},{"asset_class":"person","name":"Bryan Ball","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"person","name":"Stephen Rodin","relevance":"medium","symbol":"","type":"signatory"}],"event_type":"listing","information_gaps":["The cleaned text does not explicitly state whether the transactions were sales vs other transaction types beyond the remark about broker-assisted sale; detailed transaction codes and exact transaction nature are not fully shown.","The text snippet does not provide the prior known state (e.g., whether this Form 4 is new relative to an earlier filing) beyond the signal label 'discovery_sec_filing_delta'.","No explicit 'change vs prior' details are included in the provided text; only the existence of this Form 4 filing is evidenced."],"key_facts":["SEC filing: Form 4 (CONFORMED SUBMISSION TYPE: 4).","Issuer: Whitehawk Therapeutics, Inc. (WHWK).","Filed as of date: 2026-04-13; conform ed period of report: 2026-04-09.","Reporting owner: Bryan Ball (OWNER DATA shows reporting-owner name as BALL BRYAN).","The filing includes a remark: \u201cRepresents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.\u201d","The filing is signed by Stephen Rodin, as Attorney-in-Fact (Chief Technical Operations Officer and SVP, Manufacturing Operations)."],"numeric_claims":[{"label":"Common stock shares (first line item)","value":"50000"},{"label":"Price per share (first line item)","value":"3.57"},{"label":"Common stock shares (second line item)","value":"6596"},{"label":"Price per share (second line item)","value":"3.43"}],"primary_claim":"Form 4 for Whitehawk Therapeutics, Inc. was filed on 2026-04-13 (covering period 2026-04-09) and states the reported common stock sales were broker-assisted to satisfy tax withholding obligations upon vesting of restricted stock units.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Whitehawk Therapeutics, Inc. (WHWK) filed a Form 4 on 2026-04-13 covering transactions with a reporting owner (Bryan Ball) with a reporting period date of 2026-04-09. The filing includes broker-assisted sales to satisfy tax withholding obligations related to vesting of restricted stock units.","topics":["SEC Form 4","insider transaction","restricted stock units","tax withholding","broker-assisted sale"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Whitehawk Therapeutics, Inc. \u00b7 Filed 20260413","ticker":"WHWK","tickers":["WHWK"],"title":"WHWK filed 4","url":"https://www.sec.gov/Archives/edgar/data/1422142/0001766522-26-000009.txt"}}... |